Expression of Yes-associated protein in gastric adenocarcinoma and its clinical significance

Bo YU,Hui CHEN,Wei WANG,Yulei YIN,Li XIAO,Hua WANG,Yao LI,Yan CHEN
DOI: https://doi.org/10.11877/j.issn.1672-1535.2017.15.04.24
2017-01-01
Abstract:Objective To explore the expression of YAP protein and its relation to clinicopathological factors and prognosis in patients with gastric adenocarcinoma. Method The expression of YAP protein in gastric adenocarcinoma tissues was measured with immunohistochemical method, and its relation to clinicopathological factors and prognosis in patients with gastric adenocarcinoma was analyzed using Kaplan-Meier univariate analysis and multivariate analysis with Cox proportional hazard model. Result In gastric adenocarcinoma issues, the positive expression of YAP protein was found in the cytoplasm of 31.6%samples and in the nuclei of 22.4%samples, both significantly higher than those in nor-mal gastric mucosa (1.0% and 0.0%, respectively) (P<0.01). The positive expression of YAP protein in cytoplasm was positively correlated with the positive expression in nuclei (Sperman correlation coefficient=0.5818, P<0.0001). Results of Kaplan-Meier univariate analysis showed that the 5 year survival rate of patients with positive YAP expression in nu-clei was lower than that of patients with negative results (P<0.05). The results of multivariate analysis using Cox propor-tional hazard model showed that the expression of YAP protein could not be used as an independent predictor of progno-sis in patients with gastric adenocarcinoma (P>0.05). Conclusion Some gastric adenocarcinoma issues have high expres-sion of YAP protein, the nuclear expression of YAP protein and the poor prognosis of gastric adenocarcinoma can be used as an early diagnostic marker for this disease.
What problem does this paper attempt to address?